Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity

被引:58
作者
Paquette, JS
Fortin, JF
Blanchard, L
Tremblay, MJ
机构
[1] CHU Laval, Unite Immunoretrovirol Humaine, Ctr Rech Infectiol, Quebec City, PQ G1V 4G2, Canada
[2] Univ Laval, Fac Med, Dept Med Biol, Quebec City, PQ G1V 4G2, Canada
关键词
D O I
10.1128/JVI.72.11.9329-9336.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Using virions harvested from 293T cells stably expressing either low or high levels of surface ICAM-1, we determined that the number of virus-embedded host ICAM-1 I proteins is positively influenced by the expression level of ICAM-1 on virus producer cells. Moreover, the increase in virion-bound host cell membrane ICAM-1 led to a concomitant enhancement of virus infectivity when a T-cell-tropic strain of human immunodeficiency virus type I (HIV-1) was used. The phenomenon was also seen when primary human cells were infected with virions pseudotyped with the envelope protein from a macrophage-tropic HIV-I isolate, thus ruling out any envelope-specific effect, We also observed that target cells treated with NKI-L16, an anti-LFA-l antibody known to increase the affinity of LFA-1 for ICAM-1, were markedly more susceptible to infection with HIV-1 particles bearing on their surfaces large numbers of host-derived ICAM-1 proteins. Given that cellular activation of leukocytes is known to modify the conformational state of LFA-I and induce ICAM-1 surface expression, it is tempting to speculate that activation of virus infected cells will lead to the production of HIV-I particles bearing more host ICAM-1 on their surfaces and that such progeny virions will preferentially infect and replicate more efficiently in activated cells which are prevalent in lymphoid organs.
引用
收藏
页码:9329 / 9336
页数:8
相关论文
共 70 条
  • [31] T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1
    Fortin, JF
    Cantin, R
    Tremblay, MJ
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (03) : 2105 - 2112
  • [32] Acquisition of host cell-surface-derived molecules by HIV-1
    Frank, I
    Stoiber, H
    Godar, S
    Stockinger, H
    Steindl, F
    Katinger, HWD
    Dierich, MP
    [J]. AIDS, 1996, 10 (14) : 1611 - 1620
  • [33] GELDERBLOM H, 1987, Z NATURFORSCH C, V42, P1328
  • [34] EFFICIENT ISOLATION AND PROPAGATION OF HUMAN IMMUNODEFICIENCY VIRUS ON RECOMBINANT COLONY-STIMULATING FACTOR-1-TREATED MONOCYTES
    GENDELMAN, HE
    ORENSTEIN, JM
    MARTIN, MA
    FERRUA, C
    MITRA, R
    PHIPPS, T
    WAHL, LA
    LANE, HC
    FAUCI, AS
    BURKE, DS
    SKILLMAN, D
    MELTZER, MS
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (04) : 1428 - 1441
  • [35] Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations
    Gluschankof, P
    Mondor, I
    Gelderblom, HR
    Sattentau, QJ
    [J]. VIROLOGY, 1997, 230 (01) : 125 - 133
  • [36] ANTIBODY TO ADHESION MOLECULE LFA-1 ENHANCES PLASMA NEUTRALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    GOMEZ, MB
    HILDRETH, JEK
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (08) : 4628 - 4632
  • [37] HEDMAN H, 1992, J IMMUNOL, V149, P2295
  • [38] DIRECT IDENTIFICATION OF CLASS II HISTOCOMPATIBILITY DR PROTEINS IN PREPARATIONS OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-III
    HENDERSON, LE
    SOWDER, R
    COPELAND, TD
    OROSZLAN, S
    ARTHUR, LO
    ROBEY, WG
    FISCHINGER, PJ
    [J]. JOURNAL OF VIROLOGY, 1987, 61 (02) : 629 - 632
  • [39] ELECTRON-MICROSCOPY OF HUMAN IMMUNODEFICIENCY VIRUS
    HOCKLEY, DJ
    WOOD, RD
    JACOBS, JP
    GARRETT, AJ
    [J]. JOURNAL OF GENERAL VIROLOGY, 1988, 69 : 2455 - 2469
  • [40] NONRANDOM ASSOCIATION OF CELLULAR ANTIGENS WITH HTLV-III VIRIONS
    HOXIE, JA
    FITZHARRIS, TP
    YOUNGBAR, PR
    MATTHEWS, DM
    RACKOWSKI, JL
    RADKA, SF
    [J]. HUMAN IMMUNOLOGY, 1987, 18 (01) : 39 - 52